MONTIVIB LC KID LEVOCETIRIZINE 2.5mg. IP + MONTELUKAST SODIUM 4mg. IP

Montivib LC Kid tablets combine Levocetirizine 2.5 mg and Montelukast 4 mg for relief of allergic rhinitis and long-term asthma control in children. Main uses: relief of symptoms of seasonal allergic rhinitis (hay fever) in children, used only when other therapies have not given adequate relief or are not tolerated; relief of symptoms of perennial allergic rhinitis in children, used only when other therapies have not given adequate relief or are not tolerated; prevention and long-term treatment of asthma in children 2 years of age and older; reduction of allergic nasal symptoms such as sneezing, runny nose, nasal itching and watery eyes; reduction of itchy, irritated allergic eye symptoms.

Common side effects of Montivib LC Kid Tablet include sleepiness and drowsiness; tiredness and weakness; dry mouth; headache; fever; cough, sore throat and cold-like symptoms. Get medical help at once if you notice mood or behaviour changes such as agitation, aggression, depression, disturbed sleep or suicidal thoughts (serious neuropsychiatric events reported with Montelukast); severe allergic reactions including swelling of the face or lips and anaphylaxis; urinary retention (difficulty in passing urine).

Each Montivib LC Kid tablet contains Levocetirizine 2.5 mg + Montelukast Sodium 4 mg. The right dose and how long to take it depend on the condition, age and other medicines, so use Montivib LC Kid Tablet only as your doctor advises.

The MRP of Montivib LC Kid Tablet is ₹98 for a pack of 10x10 (Alu Alu). For chemists and distributors, the PTR is ₹74.67 and the PTS is ₹67.2.

Each Montivib LC Kid tablet contains Levocetirizine 2.5 mg + Montelukast Sodium 4 mg. It comes in a pack of 10x10 (Alu Alu).

Levocetirizine in the tablet works by blocking histamine at its H1 receptors, which brings down sneezing, a runny nose, watery eyes and itching. Montelukast Sodium acts on a different pathway by blocking cysteinyl leukotrienes in the nasal lining and air passages. These chemicals cause swelling, extra mucus and tightening of the airways during allergy, so together the two ingredients act on both histamine and leukotriene activity.

Must not be used by children with a known allergy to Levocetirizine, cetirizine, Montelukast or any ingredient of the tablet. Must not be used in end-stage kidney disease (creatinine clearance below 10 mL/min) or in patients on haemodialysis. Must not be used in children 6 months to 11 years of age with renal impairment. Must not be used to treat a sudden or acute asthma attack. Check with a doctor first if the child has liver disease or a tendency to urinary retention (for example spinal cord lesion or enlarged prostate), or is sensitive to aspirin; report any mood, sleep or behaviour change to the doctor.

Montivib LC Kid Tablet is a brand of Vibcare Pharma, sold through its Prima division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.